[1] Kitahara CM, Sosa JA.Understanding the ever-changing incidence of thyroid cancer[J]. Nat Rev Endocrinol, 2020, 16(11): 617-618. [2] Hwangbo Y, Park YJ.Genome-Wide Association Studies of Autoimmune Thyroid Diseases, Thyroid Function, and Thyroid Cancer[J]. Endocrinol Metab, 2018, 33(2): 175-184. [3] Gartland RM, Lubitz CC.Impact of Extent of Surgery on Tumor Recurrenceand Survival for Papillary Thyroid Cancer Patients[J]. Ann Surg Oncol, 2018, 25(9): 2520-2525. [4] 谢容,沈忠杰. 改良小切口手术治疗微小甲状腺癌的近期疗效及对生活质量的影响[J]. 现代肿瘤医学,2018,26(12):1838-1841. [5] Reed MD, Nostran WV.Assessing pain intensity with the visual analog scale: a plea for uniformity[J]. J Clin Pharmacol, 2014, 54(3): 241-244. [6] 汪向东,王希林,马弘. 心理卫生评定量表手册[M]. 北京:中国心理卫生杂志社,1999:235-238 [7] Zung WW.A Self Rating Depression Scale[J]. Arch Gen Psychiatry, 1965, 12(1): 63-70. [8] Elisabetta A, Cataldi S, Lazzarini A, et al.Radiation and Thyroid Cancer[J]. Int J Mol Sci, 2017, 18(5): 911. [9] Kitahara CM, Preston DL, Neta G, et al.Occupational radiation exposure and thyroid cancer incidence in a cohort of U.S. radiologic technologists, 1983-2013[J]. Int J Cancer, 2018, 143(9): 2145-2149. [10] 申红梅. 碘与甲状腺癌的关系[J]. 中华地方病学杂志,2018,37(6):431-435. [11] Zhang YL, Li P, Liu ZY, et al.Does relatively low iodine intake contribute to thyroid cancer? An ecological comparison of epidemiology[J]. Medicine, 2019, 98(41): e17539. [12] Yang X, Sun J, Han J, et al.Iodine promotes thyroid cancer development via SPANXA1 through the PI3K/AKT signalling pathway[J]. Oncol Lett, 2019, 18(1): 637-644. [13] 高再荣. 《分化型甲状腺癌术后131I治疗临床路径专家共识(2017版)》解读[J]. 中华核医学与分子影像杂志,2018,38(6):420-421. [14] 贺志刚,吴国富,杨枫,等. 促甲状腺激素抑制对分化型甲状腺癌术后患者甲状腺功能及骨密度指标的影响[J]. 中国肿瘤临床与康复,2020,27(1):72-75. [15] 高虹,刘春芝,金慧,等. 低位弧形切口在甲状腺乳头状癌颈部淋巴结转移手术治疗中的应用效果[J].实用癌症杂志,2019,34(11):1869-1871,1878. |